SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SIMIONI, Carolina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.546
AS - Asia 1.885
EU - Europa 1.717
SA - Sud America 348
AF - Africa 37
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.541
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.443
SG - Singapore 772
PL - Polonia 518
CN - Cina 503
IT - Italia 423
BR - Brasile 297
DE - Germania 219
HK - Hong Kong 161
VN - Vietnam 141
UA - Ucraina 123
GB - Regno Unito 118
TR - Turchia 90
FI - Finlandia 66
RU - Federazione Russa 59
SE - Svezia 59
CA - Canada 57
ID - Indonesia 52
IN - India 42
MX - Messico 42
FR - Francia 35
JP - Giappone 25
NL - Olanda 23
BD - Bangladesh 22
AR - Argentina 21
ZA - Sudafrica 20
BE - Belgio 16
PK - Pakistan 13
ES - Italia 12
IQ - Iraq 11
AT - Austria 10
EC - Ecuador 9
VE - Venezuela 7
LT - Lituania 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CZ - Repubblica Ceca 5
IR - Iran 5
CH - Svizzera 4
CO - Colombia 4
DZ - Algeria 4
HU - Ungheria 4
IE - Irlanda 4
KE - Kenya 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
JO - Giordania 3
KR - Corea 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CL - Cile 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
PH - Filippine 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AM - Armenia 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.541
Salva come PNG Salva come JPEG
Città #
Warsaw 516
Singapore 438
Ashburn 395
Fairfield 383
Woodbridge 280
Houston 223
Beijing 174
Chandler 172
Ferrara 167
Santa Clara 166
Seattle 157
Ann Arbor 156
Hong Kong 156
Cambridge 144
Wilmington 139
Jacksonville 128
Dallas 89
Los Angeles 74
Munich 66
Izmir 55
Milan 54
Princeton 49
Nanjing 47
New York 47
Jakarta 46
Ho Chi Minh City 41
Shanghai 37
Hanoi 29
San Diego 29
São Paulo 28
Boardman 25
Bologna 24
Dearborn 24
Dong Ket 24
Tokyo 21
Helsinki 20
Mexico City 20
Turku 19
Nanchang 18
Shenyang 18
Buffalo 17
Frankfurt am Main 17
Hefei 17
Atlanta 16
Brussels 16
Falkenstein 16
Montreal 16
Phoenix 15
Denver 14
London 14
Bengaluru 13
Rio de Janeiro 13
Montréal 12
Poplar 12
Boston 11
Changsha 11
Chennai 11
San Francisco 11
Stockholm 11
Auburn Hills 10
Johannesburg 10
Brasília 9
Brooklyn 9
Columbus 9
Council Bluffs 9
Kunming 9
Moscow 9
Nuremberg 9
Rome 9
Hebei 8
Jinan 8
Toronto 8
Ankara 7
Belo Horizonte 7
Bremen 7
Chicago 7
Manchester 7
Porto Alegre 7
Redwood City 7
Tianjin 7
Addison 6
Baghdad 6
Curitiba 6
Dhaka 6
Falls Church 6
Guangzhou 6
Hangzhou 6
Lauterbourg 6
Norwalk 6
Orem 6
Querétaro 6
Redmond 6
The Dalles 6
Zhengzhou 6
Amsterdam 5
Campinas 5
Des Moines 5
Hải Dương 5
Imola 5
Lahore 5
Totale 5.247
Salva come PNG Salva come JPEG
Nome #
Targeting mTOR in Acute Lymphoblastic Leukemia 259
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 254
PHARMACOLOGICAL CHARACTERIZATION OF THE SIGNAL TRANSDUCTION PATHWAYS MODULATED BY A3 RECEPTORS IN CANCER CELLS: POSSIBLE TARGETS FOR THERAPEUTIC INTERVENTION. 236
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 230
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 226
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 225
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 222
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 222
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 219
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 211
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 206
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 202
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 197
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 196
Adenosine receptors and cancer 188
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 183
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 174
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 170
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 156
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 152
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 152
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 149
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 145
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 142
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 142
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 134
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 131
Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies 130
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies 129
Binding thermodynamics at the human A2B adenosine receptor. 126
Legislation to limit the environmental plastic and microplastic pollution and their influence on human exposure 122
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. 120
null 112
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 107
Micrornas patterns as potential tools for diagnostic and prognostic follow‐up in cancer survivorship 104
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. 102
The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies 102
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 102
Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues 101
null 95
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 94
Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance 93
The role of extracellular vesicles as shuttles of RNA and their clinical significance as biomarkers in hepatocellular carcinoma 93
The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications 91
The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway 89
null 86
null 86
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 86
Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives 86
null 84
Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). 75
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy 74
Regulation of Second Messenger Systems and Intracellular Pathways. 51
Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection 37
Totale 7.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.345
Totale 37.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021623 0 0 0 0 0 106 67 98 46 169 69 68
2021/2022434 20 35 21 4 36 36 13 35 15 47 55 117
2022/2023467 55 36 26 42 60 49 42 31 45 30 37 14
2023/2024299 28 35 22 6 15 29 19 22 5 10 15 93
2024/20251.414 39 47 115 74 180 125 93 71 223 135 162 150
2025/20262.037 428 126 306 449 520 208 0 0 0 0 0 0
Totale 7.700